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AUTO - IMMUNITY 
FACT OR FICTION
A la sd a ir  K. T. Conn
Read before the Society Wednesday 14th January 1970
The recognition that the mammalian 
organism is capable of developing an immune 
response against its own normal tissue com­
ponents has aroused interest in the implication 
of auto-immune reactions in human disease. 
This interest may, however, be too widely 
applied, and the label “ auto-immune”  may be 
applied to a particular clinical entity with a 
complete disregard for the rather exacting 
criteria which this aetiology demands; indeed 
one might say that the word auto-immune is 
almost synonymous with the word idiopathic, 
in the clinician’s dictionary.
Some definitions first. By auto-immune 
disease it is widely understood that there is a 
failure at some point for the body to differen­
tiate between its own tissue components and 
those of a foreign material; it can no longer 
distinguish, if one likes to put it in more crude 
terms, between “ self”  and “ non-self” . Conse­
quently the host launches an immunological 
response towards its tissue components, with 
the resulting pathological changes and clinical 
manifestations.
The subject of auto-immunity has however, 
like so many other intensely investigated 
fields been clouded by vague and indeed, often 
confusing, terminology. The term auto­
immunity at present enjoys the widest use, and 
under this rather nebulous heading are included 
many diseases resulting from the reactivity of 
antibodies directed toward the host tissues. 
These diseases range from Hashimoto’s thy­
roiditis, and rare forms of haemolytic anaemia 
right through to disseminated lupus ery- 
thematosis, rheumatic fever and dermato- 
myositis.
Before we even begin to consider exactly
what significance the immunological response 
has in these diseases, we can perhaps make a 
few pertinent points.
First, it can be shown, and this will be dis­
cussed in more detail later, that the auto­
immune process plays an intricate, and perhaps 
as yet incompletely revealed part in the process 
of cellular damage. It still remains to explain 
how the process came to be in existence; so 
that, when we use the term auto-immunity we 
are describing a particular pathogenic mechan­
ism; we are not forwarding an aetiology. 
Auto-immunity is a process, like degeneration 
is a process; it does not explain how this pro­
cess came about.
Second, auto-antibodies, and, presumably, 
auto-reactive delayed hypersensitivity, can 
occur as a result of tissue damage. Trauma 
to an organ may lead to cellular necrosis and 
death, with the liberation of tissue com­
ponents, and these tissue components may 
elicit an immune response; but this need not 
be an aggressive respanse. One example 
is that of the post myocardial infarc­
tion, or Dressier, syndrome. Following myo­
cardial infarction, antiheart antibodies, as de­
tected by both indirect immofluorescence and 
antibody consumption tests were present in the 
serum of recovering patients, but absent from 
that of controls. Following recovery, the levels 
of these antiheart antibodies fell to undetect­
able levels. Dressier suggested that cardiac 
necrosis may lead to this auto-immune response. 
In rabbits certainly, animals immunised against 
rabbit heart do not develop any histological 
changes in the myocardium, despite high levels 
of circulating antibody. Kaplan found tran­
sient antiheart antibodies were sometimes
present after heart operations, especially com­
missurotomy. Antibodies to liver are found in 
rats following administration of hepatotoxic 
agents. Therefore the demonstration of an 
auto-immune response, i.e. the detection of 
antibodies towards the host’s own tissues, does 
not seem, in itself, to provide good evidence 
that tissue damage in disease has an immuno­
logical cause.
Unfortunately this concept is not so well 
instilled into many of our minds as it could 
be. Auto-immunity is not synonymous with 
auto-aggression. And yet, the immune mech­
anism need not invariably benefit the host —  
the anaphylactic response, with its often fatal 
outcome, is a dramatic example to the erring 
physician.
It may be seen that an auto-immune process 
can play a part in the perpetuation of a patho­
logical situation. A question that must be 
answered is that if, once initiated, the process 
is self-perpetuating, or whether the original 
perturbation is necessary for the continuation 
of the pathological state. In other words how 
important is the immune process in the pro­
longation of the disease. This problem can 
be tackled from several angles.
One must be immediately put on one’s 
guard by the observation that many auto­
immune antibodies can be present without 
overt pathological damage. The Wasserman 
reaction, for example, demonstrates antibody 
to cardiolipid —  a phospholipid which occurs 
in mitochondria of mammalian cells. This 
auto-antibody develops after several types of 
virus infection, including vaccination and 
glandular fever; diseases in which there may 
be minimal observed tissue damage. It is per­
haps worthwhile first to consider that perhaps 
if the spirochaete had not been observed and 
isolated in cases of syphilis, this disease too, in 
the light of a positive antibody reaction to 
heart tissue, may have been found in the ranks 
of the auto-immune disorders.
One method of determining the relationship 
of the genesis of the sensitised state to the 
prolongation of the clinical disease is to see if 
damage to the corresponding organ follows 
injection of extracts of various tissues, and if, 
once initiated in this way, the process is self 
perpetuating. Field and Laspary attempted 
this with testis and brain and found that the 
lesions produced in the target organs tended 
to decrease in intensity once the course of in­
fection was terminated. However, the organ 
that has received the greatest amount of
attention concerning this aspect of research 
has undoubtedly been the thyroid gland. It 
was early discovered that the serum of patients 
with Hashimoto’s thyroiditis contain auto­
antibodies against thyroglobulin, that this 
antibody is organ specific and that it does not 
cross react with extracts of thyroid glands from 
the six other mammalian species studied. 
Since then, antibodies toward microsomal 
thyroid antigen have been discovered. Ex­
perimental immunization of animals with 
homologous or autologous thyroid extracts 
should, and indeed does, lead to the produc­
tion of circulating thyroid antibodies and to 
lesions within the gland virtually indistinguish­
able from the pathological appearance of 
Hashimoto’s disease. There is, however, no 
consistent relationship between the level of 
circulating antibodies and the severity of thy­
roid lesions, at least in neither rats nor rabbits. 
However, the injected extract has an import­
ant bearing on the results —  aqueous prepar­
ations of thyroglobulin are rapidly catabolised 
and do not persist as a sustained stimulus. In 
the case of injections of thyroglobulin in­
corporated with complete Freund’s adjuvant 
the stimulus is sustained. Homologous thy­
roid extracts without adjuvant do not produce 
a rise in antibodies or a thyroiditis, it is only 
when thyroglobuln plus adjuvant, or thyro­
globulin that has been altered chemically by 
coupling onto a diazonium derivative is used 
that any measurable response is obtained. 
Once the hypersensitive state is attained, 
using altered thyroglobulin, subsequent injec­
tions of unaltered thyroglobulin do not per­
petuate the response indefinitely. An interest­
ing result since recent work has demonstrated 
that thyroglobulin is physiologically secreted 
into the lymphatics.
W e  saw that in the case of Hashimoto’s 
thyroiditis which has been experimentally in­
duced, the level of antibodies does not 
correlate well with the degree of pathological 
damage within the gland, and so we need to 
consider the relative importance of de­
layed hypersensitivity and antibody, or hum­
oral factors in auto-immune disease. In cer­
tain cases, for example the haemoloytic 
anaemias, the antibody is almost certainly 
more important. In the experimental field a 
transient allergic glomerulonephritis can be in­
duced by the transfer of large amounts of 
serum from an auto-immunized host develop­
ing antibodies towards its own kidney.
In other auto-immune disorders however,
delayed hypersensitivity m ay be im portant. 
Evidence that both delayed hypersensitivity 
and antibody production was im portant in the 
pathological response was forwarded by Brown 
et al, working on experim ental orchitis in 
guinea pigs. T h ey  defined a system, using 
differently prepared tissue extracts, whereby in 
some animals only antibody toward the testes 
developed, and others in which only a delayed 
hypersensitivity phenomenon developed. In 
neither case was there a characteristic orchitis. 
O nly when antibody was transferred to ani­
mals of the delayed hypersensitivity type, or 
cells transferred to the animals in whom anti­
bodies had developed was the characteristic 
testicular damage obtained. So in this experi­
m ental situation both and cell mediated 
factors may be important.
W h ilst we k now that auto-antibodies may 
be present in a large num ber of diseases, what 
do we know of the aetiology of these so called 
auto-immune diseases. There m ay be several 
ways in which the auto-immune process may 
be initiated and the aetiological factor m ight 
have to be present for the auto-immune pro­
cess to be continued. O ne needs to consider 
the several types of auto-immune disorder.
First, there is the group of diseases in which 
the auto-immune disease follows infection; and 
the obvious syndrome illustrating this is 
rheumatic fever, following a streptococcal 
infection of the throat. Kaplan has shown 
that auto-antibodies to heart occur in acute 
rheumatic fever and that some, but not all, 
of these react with streptococci. Rabbits 
immunized with streptococci develop auto­
antibodies, and antibodies toward human 
heart. It  may be that the antigens of strepto­
cocci and heart tissue are similar or it may be 
that streptococcal antigens react as haptens.
L e t us now consider some auto-immune 
diseases such as thyroiditis. Current thinking 
about aetiology o f this condition m ust surely 
change, for although the label auto-immune is 
applied, it is, as I have endeavoured to ex­
plain, merely describing the process, not the 
aetiology. Current thought revolves around 
the discovery that often a fam ily history is 
obtained in these patients, and that many 
people who are clinically normal have high 
levels of thyroid antibodies, within these 
fam ily groups. Indeed H all and Stanbury 
having recently examined a num ber of families 
affected by the condition have shown that the 
incidence approached 50%  in siblings and that 
there is almost invariably an abnormality in
one or other parent of an affected patient. 
Th is is com patible with dom inant inheritance, 
and in the fam ilies they examined figures 
approaching theoretical were obtained. In 
other fam ilies, both other genetic factors and 
indeed environm ental pressures such as iodine 
deficiency, puberty, pregnancy and viral in­
fections, may need to be suitable before the 
disease manifests itself.
Experim ents in the N ew  Zealand Black 
M ouse strain and its hybrids are also of interest 
here. M ice of this strain appear norm al at 
birth, but between four and nine months of 
age develop a haem olytic anaemia analogous 
to hum an auto-immune haem olytic anaemia. 
T h e  first abnormality detectable is that their 
circulating red cells begin to give positive 
direct antiglobulin tests and eventually the 
test becomes positive in virtually 10 0 %  of the 
mice. T h e  results of crossing of this type with 
other strains show that the auto-immune char­
acter of N Z B  m ice is expressed in different 
ways, but is present in its F 1 hybrids. It  is not 
influenced by the sex of the N Z B  parent and 
this indicates the transmission of disease to the 
offspring is not sex linked, and the m ilk factor 
does not seem to be involved.
H ow m ight —  and I assume for the process 
of hypothesis —  this genetic abnormality of 
the thyroid m anifest itself in physical terms?
It could of course be a lesion leading to 
faulty protein structure w ithin the thyroid 
follicular cell. Th is m ight lead to abnormal 
release of normal constituents and this con­
tinuing cellular damage m ight elecit the “ auto­
im m une”  response. I f  this is so, one m ight 
wonder why the clinical presentation is so late 
in life. Environm ental reasons have already 
been proffered but it  is worthwhile remember­
ing that diseases such as H untingdon’s chorea, 
widely recognised by clinicians as an auto­
somal dom inant inherited disorder, does not 
normally present until the m iddle thirties in 
those affected and it may be even later.
Th is is an attractive hypothesis, for it may 
also lead to an understanding of the assoc­
iation of auto-immune thyroiditis and o f  A ddi­
sonian pernicious anaemia, the latter being a 
disease in which over 80%  of patients have 
antibodies to gastric parietal cells. T h e  thyroid 
and the gastric mucosa have a com m on 
embryological precursor —  nam ely the endo- 
derm —  and furthermore several similar bio­
chemical functions —  for example, the ability 
to concentrate iodine. I t  m ight be considered 
that if a biochem ical defect existed in the
thyroid cell, and there are a vast number of 
possible defects, some of them might not only 
affect thyroid biochemistry, but gastric meta­
bolism as well, the two cells sharing common 
pathways.
Another defect might be that instead of the 
thyroid being abnormal there is defective con­
trol in antibody production. I find this less 
satisfying; why is the “control” always lost to 
certain specified organs —  thyroid, gastric 
mucosa, adrenal glands. O n the tissue defect 
hypothesis it might be said that if the defect 
were in a more vital tissue —  muscle, liver —  
this would be incompatible with life and the 
conception would never go to term.
T h e  aetiology of auto-immune diseases may 
also be infection. Subacute sclerosing panen­
cephalitis is a degenerative disorder of the 
brain, the exact aetiology obscure. Antibodies 
to brain were discovered in these patients and 
the label auto-immune attached to the syn­
drome. It is only recently that antibodies to 
measles virus have been isolated in these 
patients, and it may be that the virus is slowly
causing brain cell damage and subsequent 
immune response. This syndrome may be 
elevated from auto-immune status to delayed 
infection status, a much more clearly compre­
hended pathology.
And so, the course is clear. Research must 
now be directed towards distinguishing auto­
immunity as an epiphenomenon after tissue 
injury, from that which is more intimately 
concerned with the pathogenesis of specific 
disease. T h at the body can produce antibodies 
to its own cells is fact, but this does not imply 
disease, indeed the increase of lymphosarcoma 
in patients with intensive immusuppressive 
therapy, and the increase in incidence of bowel 
tumours in patients with multiple myeloma 
might suggest that immune processes play an 
important part in the clearing of cellular 
debris and the prevention of abnormal or neo­
plastic cells arising. A full answer must await 
the elucidation of the control of the immune 
response, its magnitude and direction, and a 
fuller understanding of what is so vaguely 
termed immunological response.
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